A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease

Adamantiades-Behçet’s disease is a multisystemic vasculitis with multiorgan involvement. Ocular disorders occur often in this syndrome typically in the form of a relapsing-remitting panuveitis and vasculitis and can lead to blindness as one of its most disabling complications if left untreated. Ther...

Full description

Bibliographic Details
Main Authors:	Michele Figus, Chiara Posarelli, Timothy G. Albert, Rosaria Talarico, Marco Nardi
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/120519

id	doaj-eeac0b8e8e1c4eefaea8db847d05ec46
record_format	Article
spelling	doaj-eeac0b8e8e1c4eefaea8db847d05ec462020-11-24T20:42:05ZengHindawi LimitedBioMed Research International2314-61332314-61412015-01-01201510.1155/2015/120519120519A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s DiseaseMichele Figus0Chiara Posarelli1Timothy G. Albert2Rosaria Talarico3Marco Nardi4Department of Surgical, Medical, Molecular Pathology and Department of Emergency, University of Pisa, 56100 Pisa, ItalyDepartment of Surgical, Medical, Molecular Pathology and Department of Emergency, University of Pisa, 56100 Pisa, ItalyDepartment of Surgical, Medical, Molecular Pathology and Department of Emergency, University of Pisa, 56100 Pisa, ItalyRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, ItalyDepartment of Surgical, Medical, Molecular Pathology and Department of Emergency, University of Pisa, 56100 Pisa, ItalyAdamantiades-Behçet’s disease is a multisystemic vasculitis with multiorgan involvement. Ocular disorders occur often in this syndrome typically in the form of a relapsing-remitting panuveitis and vasculitis and can lead to blindness as one of its most disabling complications if left untreated. There are known risk factors related with the worst visual prognosis, which require early and intensive treatment in order to obtain a rapid suppression of inflammation and to prevent future relapses. The management strategy to avoid vision loss and blindness currently involves the use of local and systemic drugs including steroids and immunosuppressive and biologic agents. This review aims to demonstrate how the introduction and the use of biologic agents improves the visual outcome of patients with Adamantiades-Behçet’s disease.http://dx.doi.org/10.1155/2015/120519
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Michele Figus Chiara Posarelli Timothy G. Albert Rosaria Talarico Marco Nardi
spellingShingle	Michele Figus Chiara Posarelli Timothy G. Albert Rosaria Talarico Marco Nardi A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease BioMed Research International
author_facet	Michele Figus Chiara Posarelli Timothy G. Albert Rosaria Talarico Marco Nardi
author_sort	Michele Figus
title	A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease
title_short	A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease
title_full	A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease
title_fullStr	A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease
title_full_unstemmed	A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease
title_sort	clinical picture of the visual outcome in adamantiades-behçet’s disease
publisher	Hindawi Limited
series	BioMed Research International
issn	2314-6133 2314-6141
publishDate	2015-01-01
description	Adamantiades-Behçet’s disease is a multisystemic vasculitis with multiorgan involvement. Ocular disorders occur often in this syndrome typically in the form of a relapsing-remitting panuveitis and vasculitis and can lead to blindness as one of its most disabling complications if left untreated. There are known risk factors related with the worst visual prognosis, which require early and intensive treatment in order to obtain a rapid suppression of inflammation and to prevent future relapses. The management strategy to avoid vision loss and blindness currently involves the use of local and systemic drugs including steroids and immunosuppressive and biologic agents. This review aims to demonstrate how the introduction and the use of biologic agents improves the visual outcome of patients with Adamantiades-Behçet’s disease.
url	http://dx.doi.org/10.1155/2015/120519
work_keys_str_mv	AT michelefigus aclinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT chiaraposarelli aclinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT timothygalbert aclinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT rosariatalarico aclinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT marconardi aclinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT michelefigus clinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT chiaraposarelli clinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT timothygalbert clinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT rosariatalarico clinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease AT marconardi clinicalpictureofthevisualoutcomeinadamantiadesbehcetsdisease
_version_	1716823263412224000

A Clinical Picture of the Visual Outcome in Adamantiades-Behçet’s Disease

Similar Items